RA Kyle - Concepedia

Author

RA Kyle

Mayo Clinic

Also Known As

R A Kyle, R Kyle, R. A. Kyle, R. Kyle, RA Kyle, Robert KYLE

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona WinnMed

About

RA Kyle is an author at Mayo Clinic specializing in hematology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	315
2	Immunology	3	3	111
3	Pathology	3	3	110
4	Health Sciences	1	1	131
5	Blood Transplantation	1	1	58

RA Kyle

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma [see comments] PR Greipp, JA Lust, W. Michael O’Fallon, Blood	1993	315
Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases RA Kyle, PR Greipp, W. Michael O’Fallon Blood	1986	220
Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma PR Greipp, JA Katzmann, W. Michael O’Fallon, Blood	1988	173
International Myeloma Workshop Consensus Panel 1. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 S. Vincent Rajkumar, JL Harousseau, Brian G.M. Durie, Institutional Research Information System University of Turin (University of Turin) Hematological MalignancyOncologyConsensus RecommendationsHematologyClinical Trials	2011	131
Vascular abnormalities in primary amyloidosis Karen Modesto, Angela Dispenzieri, MA Gertz, European Heart Journal	2007	62
Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation César O. Freytes, David H. Vesole, J Le-Rademacher, Bone Marrow Transplantation Transplant RejectionTransplantationHematologyTransplantation MedicineImmunology	2013	58
Why better prognostic factors for multiple myeloma are needed [editorial] [see comments] RA Kyle Blood Prognostic FactorsPrognostic EvaluationHematological MalignancyOncologyPrognosis	1994	57
Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma KA Donovan, MQ Lacy, M P Kline, Leukemia Hematological MalignancyAutoimmune DiseaseMonoclonal GammopathyMedicineMalignant Blood Disorder	1998	39
Clinical aspects of multiple myeloma and related disorders including amyloidosis. RA Kyle PubMed	1999	31
High-dose therapy in multiple myeloma and primary amyloidosis: an overview. RA Kyle PubMed	1999	26

Page 1